$216 Million is the total value of First Light Asset Management, LLC's 65 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 15.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEO | Sell | NEOGENOMICS INC | $16,393,000 | -21.6% | 2,038,988 | -34.3% | 7.60% | -28.0% |
| ATRC | Sell | ATRICURE INC | $13,036,000 | -16.5% | 922,590 | -0.5% | 6.04% | -23.3% |
| ENZ | Sell | ENZO BIOCHEM INC | $8,149,000 | +3.4% | 1,364,963 | -21.2% | 3.78% | -5.0% |
| ENTL | Sell | ENTELLUS MEDICAL INC | $7,240,000 | +0.2% | 396,291 | -0.2% | 3.35% | -8.0% |
| TLGT | Sell | TELIGENT INC | $7,194,000 | +44.1% | 1,007,530 | -1.1% | 3.33% | +32.3% |
| AMED | Sell | AMEDISYS INC | $6,097,000 | -14.1% | 120,778 | -17.7% | 2.82% | -21.1% |
| NXTM | Sell | NXSTAGE MEDICAL INC | $5,509,000 | +42.5% | 254,113 | -1.5% | 2.55% | +30.9% |
| LMAT | Sell | LEMAITRE VASCULAR INC | $5,502,000 | -9.6% | 385,562 | -1.7% | 2.55% | -17.0% |
| LGND | Sell | LIGAND PHARMACEUTICALS INC | $5,024,000 | -17.3% | 42,120 | -25.7% | 2.33% | -24.0% |
| EVHC | Sell | ENVISION HEALTHCARE HOLDINGS INC | $4,870,000 | +3.6% | 191,946 | -16.7% | 2.26% | -4.9% |
| BEAT | Sell | BIOTELEMETRY INC | $4,159,000 | -2.4% | 255,163 | -30.1% | 1.93% | -10.4% |
| LDRH | Sell | LDR HOLDING CORPORATION | $3,909,000 | -14.8% | 105,780 | -41.2% | 1.81% | -21.7% |
| SPNC | Sell | SPECTRANETICS CORP | $3,709,000 | -9.8% | 198,219 | -30.0% | 1.72% | -17.2% |
| RTIX | Sell | RTI BIOLOGICS INC | $3,544,000 | -11.8% | 987,225 | -1.7% | 1.64% | -19.0% |
| DOC | Sell | PHYSICIANS REALTY TRUST | $3,274,000 | +11.4% | 155,849 | -1.5% | 1.52% | +2.3% |
| ELGX | Sell | ENDOLOGIX INC | $3,220,000 | -27.3% | 258,431 | -51.3% | 1.49% | -33.3% |
| CYNA | Sell | CYNAPSUS THERAPEUTICS INC | $3,159,000 | +38.2% | 188,577 | -1.8% | 1.46% | +26.9% |
| BLUE | Sell | BLUEBIRD BIO INC | $2,902,000 | +0.2% | 67,044 | -1.6% | 1.34% | -7.9% |
| VCYT | Sell | VERACYTE INC | $2,746,000 | -8.6% | 546,021 | -1.9% | 1.27% | -16.1% |
| TECH | Sell | BIO TECHNE CORP | $2,723,000 | +17.6% | 24,146 | -1.5% | 1.26% | +8.0% |
| ALKS | Sell | ALKERMES PLC | $2,683,000 | +24.1% | 62,068 | -1.8% | 1.24% | +13.9% |
| IMMU | Sell | IMMUNOMEDICS INC | $2,292,000 | -40.6% | 987,854 | -36.0% | 1.06% | -45.5% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $2,050,000 | +6.2% | 23,835 | -1.8% | 0.95% | -2.5% |
| CPHD | Sell | CEPHEID | $1,912,000 | -9.5% | 62,178 | -1.8% | 0.89% | -16.9% |
| QDEL | Sell | QUIDEL CORP | $1,495,000 | -41.6% | 83,698 | -43.6% | 0.69% | -46.3% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $1,440,000 | -7.4% | 18,515 | -1.8% | 0.67% | -14.9% |
| AGRX | Sell | AGILE THERAPEUTICS | $454,000 | +18.8% | 59,701 | -2.9% | 0.21% | +8.8% |
| STJ | Sell | ST JUDE MED INC | $305,000 | -8.4% | 3,911 | -35.4% | 0.14% | -16.1% |
| ENDP | Exit | ENDO INTL PLC | $0 | – | -8,161 | -100.0% | -0.12% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC | $0 | – | -210,807 | -100.0% | -0.40% | – |
| INSM | Exit | INSMED INC | $0 | – | -177,930 | -100.0% | -1.14% | – |
| ARWR | Exit | ARROWHEAD RESEARCH CORP | $0 | – | -491,574 | -100.0% | -1.20% | – |
| ANGO | Exit | ANGIODYNAMICS INC | $0 | – | -273,122 | -100.0% | -1.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 43 | Q2 2024 | 9.7% |
| NEOGENOMICS INC | 43 | Q2 2024 | 10.6% |
| SANOFI-SYNTHELABO | 41 | Q4 2023 | 1.9% |
| JOHNSON & JOHNSON | 41 | Q4 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 37 | Q4 2023 | 1.6% |
| NOVARTIS AG-SPONSORED ADR | 34 | Q4 2023 | 0.4% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| MODEL N INC | 32 | Q1 2024 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| OptimizeRx Corp | June 10, 2024 | 1,829,074 | 10.0% |
| TELA Bio, Inc.Sold out | June 10, 2024 | 0 | 0.0% |
| Societal CDMO, Inc. | April 09, 2024 | ? | ? |
| KORU Medical Systems, Inc. | February 14, 2024 | 5,158,444 | 11.3% |
| Performant Financial Corp | February 14, 2024 | 9,696,781 | 12.6% |
| PLIANT THERAPEUTICS, INC. | February 14, 2024 | 3,634,510 | 6.1% |
| SI-BONE, Inc. | February 14, 2024 | 2,532,227 | 6.2% |
| Sonendo, Inc. | February 14, 2024 | 5,446,491 | 10.0% |
| Miromatrix Medical Inc. | December 07, 2023 | 2,592,022 | 9.4% |
| Orthofix Medical Inc.Sold out | October 30, 2023 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-15 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-08-09 |
| SC 13G/A | 2024-07-10 |
| SC 13G/A | 2024-06-10 |
| SC 13G/A | 2024-06-10 |
| 13F-HR | 2024-05-15 |
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.